Author:
Alnaji Raed M.,Du William,Gabriel Emmanuel,Singla Smit,Attwood Kristopher,Nava Hector,Malhotra Usha,Hochwald Steven N.,Kukar Moshim
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/ , based on November 2014 SEER data submission.
2. National Comprehensive Cancer Network. Esophagus: version 3.2015. http://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf . Published 2015. Accessed November 24, 2015.
3. Donahue JM, Nichols FC, Li Z, et al. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg. 2009;87(2):392-8. Medline: 19161745
4. Kukar M, Alnaji RM, Jabi F, et al. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma. JAMA Surg. 2015;150(6):555-62. Medline: 25902198
5. Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol. 2005;23(19):4330-7. Medline: 15781882
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献